Peer review reports
From: Targeting PCSK9 to upregulate MHC-II on the surface of tumor cells in tumor immunotherapy
Original Submission | ||
---|---|---|
12 Oct 2023 | Submitted | Original manuscript |
30 Oct 2023 | Reviewed | Reviewer Report |
9 Nov 2023 | Reviewed | Reviewer Report |
21 Jan 2024 | Author responded | Author comments - Jia Wei |
Resubmission - Version 2 | ||
21 Jan 2024 | Submitted | Manuscript version 2 |
24 Jan 2024 | Author responded | Author comments - Jia Wei |
Resubmission - Version 3 | ||
24 Jan 2024 | Submitted | Manuscript version 3 |
26 Jan 2024 | Author responded | Author comments - Jia Wei |
Resubmission - Version 4 | ||
26 Jan 2024 | Submitted | Manuscript version 4 |
7 Feb 2024 | Reviewed | Reviewer Report |
9 Feb 2024 | Reviewed | Reviewer Report |
17 Feb 2024 | Author responded | Author comments - Jia Wei |
Resubmission - Version 5 | ||
17 Feb 2024 | Submitted | Manuscript version 5 |
23 Feb 2024 | Author responded | Author comments - Jia Wei |
Resubmission - Version 6 | ||
23 Feb 2024 | Submitted | Manuscript version 6 |
12 Mar 2024 | Reviewed | Reviewer Report |
18 Mar 2024 | Reviewed | Reviewer Report |
19 Mar 2024 | Author responded | Author comments - Jia Wei |
Resubmission - Version 7 | ||
19 Mar 2024 | Submitted | Manuscript version 7 |
Publishing | ||
20 Mar 2024 | Editorially accepted | |
10 Apr 2024 | Article published | 10.1186/s12885-024-12148-2 |